- Home
- MG vs CYRX Comparison
MG vs CYRX Comparison
Compare MG & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MG | CYRX |
|---|---|---|
| Founded | 1978 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Military/Government/Technical | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.7M | 421.6M |
| IPO Year | 2008 | 2008 |
Fundamental Metrics
Financial Performance| Metric | MG | CYRX |
|---|---|---|
| Price | $14.20 | $7.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $12.94 |
| AVG Volume (30 Days) | 149.9K | ★ 367.2K |
| Earning Date | 06-10-2026 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | 0.53 | ★ 1.40 |
| Revenue | ★ $700,970,000.00 | $176,177,000.00 |
| Revenue This Year | $5.23 | $9.71 |
| Revenue Next Year | $3.13 | $9.56 |
| P/E Ratio | $35.22 | ★ $5.72 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.06 | $4.63 |
| 52 Week High | $15.84 | $11.45 |
Technical Indicators
Market Signals| Indicator | MG | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 43.44 | 34.81 |
| Support Level | $13.80 | $6.57 |
| Resistance Level | $14.96 | $7.88 |
| Average True Range (ATR) | 0.73 | 0.45 |
| MACD | -0.15 | -0.01 |
| Stochastic Oscillator | 41.31 | 8.57 |
Price Performance
Historical ComparisonAbout MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.